| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Platelet Activating Factor | 18 | 2013 | 19 | 2.450 |
Why?
|
| Lung | 20 | 2014 | 106 | 2.080 |
Why?
|
| Muscle, Smooth, Vascular | 12 | 2013 | 31 | 2.020 |
Why?
|
| Receptors, G-Protein-Coupled | 11 | 2016 | 18 | 1.960 |
Why?
|
| Platelet Membrane Glycoproteins | 10 | 2016 | 10 | 1.850 |
Why?
|
| Pulmonary Artery | 11 | 2016 | 15 | 1.510 |
Why?
|
| Hypoxia | 10 | 2016 | 37 | 1.460 |
Why?
|
| Myocytes, Smooth Muscle | 4 | 2016 | 27 | 1.160 |
Why?
|
| Animals, Newborn | 17 | 2014 | 112 | 1.020 |
Why?
|
| Sheep | 26 | 2016 | 132 | 0.990 |
Why?
|
| Oxygen | 10 | 2016 | 44 | 0.920 |
Why?
|
| Pulmonary Veins | 9 | 2010 | 9 | 0.900 |
Why?
|
| Albuterol | 3 | 2011 | 3 | 0.880 |
Why?
|
| Bronchodilator Agents | 3 | 2011 | 3 | 0.880 |
Why?
|
| Animals | 38 | 2016 | 1875 | 0.870 |
Why?
|
| Cell Proliferation | 8 | 2013 | 143 | 0.730 |
Why?
|
| Leukotrienes | 7 | 2001 | 7 | 0.590 |
Why?
|
| Hyperoxia | 3 | 2016 | 18 | 0.590 |
Why?
|
| Asthma | 2 | 2008 | 31 | 0.500 |
Why?
|
| Persistent Fetal Circulation Syndrome | 1 | 2016 | 1 | 0.490 |
Why?
|
| Oxygen Inhalation Therapy | 1 | 2016 | 5 | 0.490 |
Why?
|
| Epoprostenol | 7 | 1997 | 7 | 0.440 |
Why?
|
| Pregnancy | 15 | 2010 | 599 | 0.420 |
Why?
|
| Fetal Hypoxia | 4 | 2016 | 10 | 0.420 |
Why?
|
| rhoA GTP-Binding Protein | 1 | 2013 | 3 | 0.410 |
Why?
|
| rho-Associated Kinases | 1 | 2013 | 2 | 0.410 |
Why?
|
| Female | 24 | 2016 | 4060 | 0.400 |
Why?
|
| Phospholipases A | 4 | 2002 | 6 | 0.400 |
Why?
|
| Thromboxane A2 | 5 | 1997 | 5 | 0.400 |
Why?
|
| NF-kappa B | 3 | 2008 | 56 | 0.400 |
Why?
|
| Bronchi | 1 | 2011 | 3 | 0.360 |
Why?
|
| Cells, Cultured | 10 | 2013 | 234 | 0.330 |
Why?
|
| Fetus | 8 | 2010 | 125 | 0.320 |
Why?
|
| Receptors, Cell Surface | 2 | 2000 | 29 | 0.300 |
Why?
|
| Signal Transduction | 4 | 2016 | 246 | 0.300 |
Why?
|
| Anemia, Sickle Cell | 4 | 1997 | 7 | 0.300 |
Why?
|
| Arachidonic Acid | 7 | 2001 | 10 | 0.290 |
Why?
|
| Arachidonic Acids | 3 | 1995 | 8 | 0.290 |
Why?
|
| Cyclin-Dependent Kinases | 1 | 2008 | 1 | 0.280 |
Why?
|
| Cyclic GMP | 3 | 2007 | 22 | 0.280 |
Why?
|
| Calcimycin | 3 | 1992 | 15 | 0.270 |
Why?
|
| Aging | 7 | 1997 | 105 | 0.260 |
Why?
|
| 8-Bromo Cyclic Adenosine Monophosphate | 1 | 2006 | 2 | 0.250 |
Why?
|
| Cyclic AMP | 4 | 2016 | 30 | 0.250 |
Why?
|
| Adrenergic beta-Agonists | 1 | 2006 | 1 | 0.240 |
Why?
|
| Pulmonary Circulation | 6 | 2000 | 6 | 0.240 |
Why?
|
| Muscle, Smooth | 1 | 2006 | 22 | 0.240 |
Why?
|
| Azepines | 4 | 2011 | 5 | 0.240 |
Why?
|
| Triazoles | 4 | 2011 | 12 | 0.230 |
Why?
|
| Arachidonate 5-Lipoxygenase | 4 | 1997 | 5 | 0.200 |
Why?
|
| Lung Injury | 2 | 2014 | 9 | 0.190 |
Why?
|
| PPAR gamma | 2 | 2014 | 51 | 0.180 |
Why?
|
| Thiazolidinediones | 2 | 2014 | 39 | 0.180 |
Why?
|
| In Vitro Techniques | 9 | 2001 | 72 | 0.180 |
Why?
|
| Flavonoids | 2 | 2013 | 6 | 0.170 |
Why?
|
| Phosphorylation | 5 | 2008 | 73 | 0.170 |
Why?
|
| Vasoconstriction | 5 | 2016 | 8 | 0.170 |
Why?
|
| Aristolochic Acids | 1 | 2000 | 1 | 0.160 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2000 | 34 | 0.160 |
Why?
|
| Inositol 1,4,5-Trisphosphate | 2 | 2011 | 9 | 0.150 |
Why?
|
| Cell Line | 2 | 2011 | 124 | 0.150 |
Why?
|
| Protein Kinase C | 3 | 2016 | 31 | 0.140 |
Why?
|
| 1-Alkyl-2-acetylglycerophosphocholine Esterase | 4 | 2002 | 4 | 0.140 |
Why?
|
| Nitric Oxide | 3 | 2007 | 47 | 0.140 |
Why?
|
| Inositol Phosphates | 2 | 2010 | 7 | 0.140 |
Why?
|
| ErbB Receptors | 2 | 2009 | 13 | 0.140 |
Why?
|
| Humans | 10 | 2011 | 6794 | 0.140 |
Why?
|
| Microsomes | 2 | 1995 | 4 | 0.140 |
Why?
|
| Platelet Aggregation Inhibitors | 3 | 2006 | 17 | 0.130 |
Why?
|
| Cyclic GMP-Dependent Protein Kinases | 2 | 2007 | 2 | 0.130 |
Why?
|
| Calcium | 2 | 2010 | 117 | 0.130 |
Why?
|
| Retinoblastoma Protein | 2 | 2008 | 3 | 0.130 |
Why?
|
| Nitric Oxide Synthase Type III | 2 | 2007 | 13 | 0.130 |
Why?
|
| Erythrocytes | 1 | 1997 | 14 | 0.130 |
Why?
|
| Endothelial Cells | 2 | 2007 | 17 | 0.130 |
Why?
|
| Endothelium, Vascular | 5 | 2001 | 30 | 0.120 |
Why?
|
| Protein Binding | 1 | 2016 | 29 | 0.120 |
Why?
|
| Dinoprostone | 4 | 1997 | 6 | 0.120 |
Why?
|
| Pulmonary Gas Exchange | 1 | 2016 | 4 | 0.120 |
Why?
|
| Thalamus | 1 | 2016 | 3 | 0.120 |
Why?
|
| Oxygen Consumption | 1 | 2016 | 13 | 0.120 |
Why?
|
| Respiratory Center | 1 | 2016 | 8 | 0.120 |
Why?
|
| Betamethasone | 1 | 1996 | 4 | 0.120 |
Why?
|
| Gestational Age | 1 | 1996 | 58 | 0.120 |
Why?
|
| RNA, Messenger | 2 | 2010 | 190 | 0.120 |
Why?
|
| Glucocorticoids | 1 | 1996 | 65 | 0.120 |
Why?
|
| Lipoxygenase | 1 | 1995 | 1 | 0.110 |
Why?
|
| Mutation | 2 | 2013 | 97 | 0.110 |
Why?
|
| Rats | 5 | 2014 | 571 | 0.110 |
Why?
|
| Time Factors | 4 | 2007 | 321 | 0.110 |
Why?
|
| Dose-Response Relationship, Drug | 4 | 2008 | 155 | 0.110 |
Why?
|
| Carbazoles | 1 | 1994 | 4 | 0.110 |
Why?
|
| Carcinogens | 1 | 1994 | 11 | 0.110 |
Why?
|
| Blood Platelets | 3 | 2001 | 9 | 0.100 |
Why?
|
| Leukotriene C4 | 3 | 2001 | 3 | 0.100 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 1 | 2013 | 5 | 0.100 |
Why?
|
| 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine | 1 | 2013 | 7 | 0.100 |
Why?
|
| Cell Hypoxia | 1 | 2013 | 7 | 0.100 |
Why?
|
| Amides | 1 | 2013 | 4 | 0.100 |
Why?
|
| Imidazoles | 1 | 2013 | 13 | 0.100 |
Why?
|
| Pyridines | 1 | 2013 | 24 | 0.100 |
Why?
|
| Down-Regulation | 2 | 2010 | 57 | 0.100 |
Why?
|
| Enzyme Inhibitors | 3 | 2007 | 53 | 0.090 |
Why?
|
| Male | 8 | 2016 | 3671 | 0.090 |
Why?
|
| Blotting, Western | 2 | 2008 | 110 | 0.090 |
Why?
|
| Rats, Sprague-Dawley | 4 | 2014 | 282 | 0.080 |
Why?
|
| Prostaglandin-Endoperoxide Synthases | 5 | 1994 | 5 | 0.080 |
Why?
|
| Eicosanoids | 4 | 1995 | 4 | 0.080 |
Why?
|
| Molecular Sequence Data | 2 | 2000 | 70 | 0.080 |
Why?
|
| Structure-Activity Relationship | 2 | 2008 | 9 | 0.080 |
Why?
|
| Altitude | 1 | 2009 | 3 | 0.070 |
Why?
|
| Perfusion | 5 | 1997 | 8 | 0.070 |
Why?
|
| Enzyme Activation | 3 | 2007 | 39 | 0.070 |
Why?
|
| Cyclin-Dependent Kinase 4 | 1 | 2008 | 1 | 0.070 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2008 | 10 | 0.070 |
Why?
|
| Cyclin-Dependent Kinase 2 | 1 | 2008 | 4 | 0.070 |
Why?
|
| Leukotriene B4 | 2 | 2001 | 2 | 0.070 |
Why?
|
| Leukotriene D4 | 2 | 2001 | 2 | 0.070 |
Why?
|
| Leukotriene E4 | 2 | 2001 | 2 | 0.070 |
Why?
|
| Platelet-Derived Growth Factor | 1 | 2008 | 3 | 0.070 |
Why?
|
| I-kappa B Kinase | 1 | 2008 | 5 | 0.070 |
Why?
|
| Drug Synergism | 1 | 2008 | 26 | 0.070 |
Why?
|
| Interleukin-6 | 1 | 2008 | 45 | 0.070 |
Why?
|
| Altitude Sickness | 1 | 2007 | 2 | 0.070 |
Why?
|
| Membrane Lipids | 1 | 2007 | 4 | 0.070 |
Why?
|
| Organelles | 1 | 2007 | 4 | 0.070 |
Why?
|
| Epidermal Growth Factor | 1 | 2007 | 8 | 0.060 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2006 | 8 | 0.060 |
Why?
|
| Caveolin 1 | 1 | 2006 | 4 | 0.060 |
Why?
|
| Norepinephrine | 1 | 2006 | 10 | 0.060 |
Why?
|
| Cytosol | 4 | 2007 | 26 | 0.060 |
Why?
|
| Acupuncture Points | 1 | 2006 | 5 | 0.060 |
Why?
|
| Skin | 1 | 2006 | 10 | 0.060 |
Why?
|
| Phospholipid Ethers | 1 | 2006 | 1 | 0.060 |
Why?
|
| Propanolamines | 1 | 2006 | 1 | 0.060 |
Why?
|
| Isoproterenol | 1 | 2006 | 2 | 0.060 |
Why?
|
| Colforsin | 1 | 2006 | 7 | 0.060 |
Why?
|
| Chromones | 1 | 2006 | 6 | 0.060 |
Why?
|
| Morpholines | 1 | 2006 | 6 | 0.060 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2006 | 11 | 0.060 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2006 | 19 | 0.060 |
Why?
|
| Vasoconstrictor Agents | 2 | 1998 | 5 | 0.060 |
Why?
|
| Proteins | 2 | 1996 | 41 | 0.060 |
Why?
|
| Cell Membrane | 2 | 2007 | 54 | 0.060 |
Why?
|
| Glutathione | 2 | 1995 | 14 | 0.060 |
Why?
|
| Prostaglandins | 3 | 1994 | 7 | 0.060 |
Why?
|
| Adult | 4 | 1997 | 2113 | 0.050 |
Why?
|
| Candida albicans | 2 | 1994 | 6 | 0.050 |
Why?
|
| Diacylglycerol Cholinephosphotransferase | 1 | 2002 | 1 | 0.050 |
Why?
|
| Phospholipases A2 | 1 | 2002 | 3 | 0.050 |
Why?
|
| Acetyl-CoA C-Acetyltransferase | 1 | 2002 | 2 | 0.050 |
Why?
|
| Choline | 1 | 2002 | 7 | 0.050 |
Why?
|
| Vascular Resistance | 3 | 1998 | 7 | 0.050 |
Why?
|
| Endothelins | 2 | 1992 | 2 | 0.050 |
Why?
|
| Pulmonary Alveoli | 2 | 2014 | 33 | 0.050 |
Why?
|
| Blood Pressure | 3 | 1998 | 112 | 0.050 |
Why?
|
| Adaptation, Physiological | 1 | 2001 | 13 | 0.040 |
Why?
|
| Lipoxygenase Inhibitors | 1 | 2001 | 2 | 0.040 |
Why?
|
| Benzoquinones | 1 | 2001 | 4 | 0.040 |
Why?
|
| Pyridinium Compounds | 1 | 2001 | 6 | 0.040 |
Why?
|
| Cell Adhesion | 2 | 2007 | 19 | 0.040 |
Why?
|
| Radioligand Assay | 1 | 2000 | 4 | 0.040 |
Why?
|
| Tritium | 1 | 2000 | 4 | 0.040 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 2000 | 5 | 0.040 |
Why?
|
| Binding, Competitive | 1 | 2000 | 11 | 0.040 |
Why?
|
| DNA, Complementary | 1 | 2000 | 10 | 0.040 |
Why?
|
| Phenanthrenes | 1 | 2000 | 1 | 0.040 |
Why?
|
| Cell Extracts | 1 | 2000 | 2 | 0.040 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2000 | 90 | 0.040 |
Why?
|
| Enzyme Induction | 1 | 2000 | 9 | 0.040 |
Why?
|
| Binding Sites | 1 | 2000 | 24 | 0.040 |
Why?
|
| Amino Acid Sequence | 1 | 2000 | 38 | 0.040 |
Why?
|
| Kinetics | 1 | 2000 | 69 | 0.040 |
Why?
|
| Microcirculation | 3 | 2007 | 14 | 0.040 |
Why?
|
| Phosphoric Diester Hydrolases | 1 | 1998 | 2 | 0.040 |
Why?
|
| Muscle Tonus | 1 | 1998 | 1 | 0.040 |
Why?
|
| Angiotensin II | 1 | 1998 | 18 | 0.040 |
Why?
|
| Hydrogen-Ion Concentration | 2 | 1996 | 34 | 0.040 |
Why?
|
| Sheep, Domestic | 2 | 2009 | 7 | 0.040 |
Why?
|
| Tyrphostins | 2 | 2009 | 3 | 0.030 |
Why?
|
| Quinazolines | 2 | 2009 | 4 | 0.030 |
Why?
|
| Hydroxyeicosatetraenoic Acids | 2 | 1995 | 2 | 0.030 |
Why?
|
| Rabbits | 3 | 1992 | 48 | 0.030 |
Why?
|
| Immunoblotting | 1 | 1997 | 16 | 0.030 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 1997 | 35 | 0.030 |
Why?
|
| Serine | 2 | 2007 | 3 | 0.030 |
Why?
|
| Acid-Base Equilibrium | 1 | 1997 | 4 | 0.030 |
Why?
|
| Analysis of Variance | 1 | 1997 | 63 | 0.030 |
Why?
|
| Nitric Oxide Donors | 2 | 2007 | 8 | 0.030 |
Why?
|
| Muscle Relaxation | 1 | 1996 | 2 | 0.030 |
Why?
|
| Age Factors | 1 | 1997 | 193 | 0.030 |
Why?
|
| Population | 1 | 1996 | 2 | 0.030 |
Why?
|
| Vasodilation | 1 | 1996 | 5 | 0.030 |
Why?
|
| DNA | 1 | 1996 | 39 | 0.030 |
Why?
|
| Feedback, Physiological | 1 | 2016 | 4 | 0.030 |
Why?
|
| Mesenteric Arteries | 1 | 1996 | 6 | 0.030 |
Why?
|
| Carbon Dioxide | 1 | 1996 | 17 | 0.030 |
Why?
|
| Femoral Artery | 1 | 1996 | 13 | 0.030 |
Why?
|
| Ferrets | 2 | 1992 | 2 | 0.030 |
Why?
|
| Thromboxane B2 | 1 | 1994 | 1 | 0.030 |
Why?
|
| Molecular Structure | 1 | 1994 | 8 | 0.030 |
Why?
|
| Nebulizers and Vaporizers | 1 | 2014 | 2 | 0.030 |
Why?
|
| Bronchoalveolar Lavage | 1 | 2014 | 2 | 0.030 |
Why?
|
| Surface-Active Agents | 1 | 2014 | 5 | 0.030 |
Why?
|
| Administration, Inhalation | 1 | 2014 | 9 | 0.030 |
Why?
|
| Leukocytes | 1 | 1994 | 9 | 0.030 |
Why?
|
| Cell Differentiation | 1 | 2014 | 101 | 0.020 |
Why?
|
| Inflammation | 1 | 1994 | 143 | 0.020 |
Why?
|
| Hemodynamics | 1 | 1992 | 34 | 0.020 |
Why?
|
| Thromboxanes | 1 | 1992 | 1 | 0.020 |
Why?
|
| Stimulation, Chemical | 1 | 1992 | 15 | 0.020 |
Why?
|
| Radioimmunoassay | 1 | 1992 | 26 | 0.020 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 1992 | 18 | 0.020 |
Why?
|
| Vasomotor System | 1 | 1991 | 1 | 0.020 |
Why?
|
| Pentoxifylline | 1 | 1991 | 3 | 0.020 |
Why?
|
| Middle Aged | 2 | 1994 | 2108 | 0.020 |
Why?
|
| Fibroblasts | 1 | 2010 | 53 | 0.020 |
Why?
|
| Proliferating Cell Nuclear Antigen | 1 | 2009 | 5 | 0.020 |
Why?
|
| Actins | 1 | 2009 | 28 | 0.020 |
Why?
|
| Cyclodextrins | 1 | 2007 | 1 | 0.020 |
Why?
|
| Fluoresceins | 1 | 2007 | 2 | 0.020 |
Why?
|
| Fluorescent Dyes | 1 | 2007 | 5 | 0.020 |
Why?
|
| Microscopy, Fluorescence | 1 | 2007 | 8 | 0.020 |
Why?
|
| Protein Subunits | 1 | 2007 | 7 | 0.020 |
Why?
|
| Protein Transport | 1 | 2007 | 23 | 0.020 |
Why?
|
| Nitroso Compounds | 1 | 2007 | 7 | 0.020 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2007 | 17 | 0.020 |
Why?
|
| Endoplasmic Reticulum | 1 | 2007 | 21 | 0.020 |
Why?
|
| Birth Weight | 1 | 2007 | 33 | 0.020 |
Why?
|
| Cell Nucleus | 1 | 2007 | 38 | 0.020 |
Why?
|
| Matrix Metalloproteinase Inhibitors | 1 | 2007 | 1 | 0.020 |
Why?
|
| Heparin-binding EGF-like Growth Factor | 1 | 2007 | 1 | 0.020 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2007 | 7 | 0.020 |
Why?
|
| Matrix Metalloproteinase 2 | 1 | 2007 | 8 | 0.020 |
Why?
|
| Dipeptides | 1 | 2007 | 6 | 0.020 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2007 | 11 | 0.020 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2007 | 14 | 0.020 |
Why?
|
| Transfection | 1 | 2007 | 56 | 0.020 |
Why?
|
| Bacterial Proteins | 1 | 2007 | 10 | 0.020 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2007 | 21 | 0.020 |
Why?
|
| GTP-Binding Protein alpha Subunits, Gi-Go | 1 | 2006 | 1 | 0.020 |
Why?
|
| Threonine | 1 | 2006 | 2 | 0.020 |
Why?
|
| Endocytosis | 1 | 2006 | 3 | 0.020 |
Why?
|
| Pertussis Toxin | 1 | 2006 | 3 | 0.020 |
Why?
|
| Antibody Specificity | 1 | 2006 | 5 | 0.020 |
Why?
|
| Chronic Disease | 1 | 2007 | 167 | 0.020 |
Why?
|
| Diethylamines | 1 | 2006 | 1 | 0.020 |
Why?
|
| Reactive Oxygen Species | 1 | 2006 | 45 | 0.020 |
Why?
|
| Sympathetic Nervous System | 1 | 2006 | 7 | 0.020 |
Why?
|
| Arginine | 1 | 2006 | 20 | 0.020 |
Why?
|
| Phospholipases | 2 | 1994 | 2 | 0.010 |
Why?
|
| Indomethacin | 2 | 1992 | 4 | 0.010 |
Why?
|
| Purinones | 1 | 1998 | 1 | 0.010 |
Why?
|
| Rolipram | 1 | 1998 | 1 | 0.010 |
Why?
|
| Pyrrolidinones | 1 | 1998 | 2 | 0.010 |
Why?
|
| Hydrolysis | 1 | 1998 | 5 | 0.010 |
Why?
|
| Phosphodiesterase Inhibitors | 1 | 1998 | 8 | 0.010 |
Why?
|
| Platelet Count | 1 | 1997 | 6 | 0.010 |
Why?
|
| Hemoglobins | 1 | 1997 | 30 | 0.010 |
Why?
|
| Body Weight | 1 | 1997 | 90 | 0.010 |
Why?
|
| Membranes | 1 | 1996 | 2 | 0.010 |
Why?
|
| Adolescent | 1 | 1997 | 869 | 0.010 |
Why?
|
| 6-Ketoprostaglandin F1 alpha | 1 | 1994 | 1 | 0.010 |
Why?
|
| Cardiac Output | 1 | 1992 | 4 | 0.010 |
Why?
|
| Anesthesia | 1 | 1992 | 8 | 0.010 |
Why?
|
| Hydrazines | 1 | 1992 | 2 | 0.010 |
Why?
|
| Fatty Acids, Unsaturated | 1 | 1992 | 4 | 0.010 |
Why?
|
| Bridged Bicyclo Compounds, Heterocyclic | 1 | 1992 | 4 | 0.010 |
Why?
|
| Prostaglandin Endoperoxides, Synthetic | 1 | 1992 | 1 | 0.010 |
Why?
|
| Species Specificity | 1 | 1991 | 17 | 0.010 |
Why?
|
| Papaverine | 1 | 1991 | 1 | 0.010 |
Why?
|
| Potassium Chloride | 1 | 1991 | 5 | 0.010 |
Why?
|
| Vasodilator Agents | 1 | 1991 | 7 | 0.010 |
Why?
|